HealthCare Ventures

HealthCare Ventures

HealthCare Ventures is a venture capital firm that invests in early clinical stage companies.

HealthCare Ventures is a Massachusetts based life science venture capital firm founded in 1985. The firm prefers to invest in pre-clinical or early clinical-stage companies. HealthCare Ventures has raised $1.6 billion in nine funds and invested in 107 companies, 68 as startup ventures.

The notable investment portfolio of HealthCare Ventures includes Catalyst Biosciences, DecImmune Therapeutics, GITR, Mosaic Biosciences, Pathogenetix, Promedior, Proteostasis Therapeutics, Radius Health, Senseonics, and Theraclone Sciences.

Timeline

1985

Founded

Funded Companies

Company
Description
Website
Industry
Location

A company developing tools for the prevention, diagnosis and management of HPV, HIV, heart failure, diabetes, fertility and blood coagulation

Biotechnology company developing synthetic materials for native tissue regeneration and tissue engineering platforms

A company ofering analytical, biomanufacturing and consumable labware products for biological research and drug discovery applications

A company developing drug therapies for osteoporosis and women’s health

A biodefense company developing medical countermeasures against threats of biological and chemical weapons

A biotechnology company that develops therapeutic antibodies for treating infectious diseases and inflammation

A biopharmaceutical company focused on the development of therapies for medical needs such as analgesic to treat moderate-to-severe acute pain

A pharmaceutical company developing products to address hemophilia

PathoGenetiX is a company for identification of pathogenic bacterial strains

A company developing vaccines for flu, malaria, dengue, papillomavirus and respiratory syncytial virus

A clinical laboratory and cardiovascular disease management company

A biotechnology company developing targeted therapeutics for the treatment of fibrosis and other diseases

A medical diagnostic device company for recovery of rare cells from blood

A company developing pepducin technology to produce therapeutics for regenerative medicine, diabetes, inflammation and cancer.

A pharmaceutical company focused developing products for pain management and women’s healthcare

A biotechnology company developing peptides and antibodies for inflammation and autoimmunity

A company developing antiviral medicines focused on ffighting drug-resistant viruses

A pharmaceutical company specializing on women’s health products

21 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Douglas Onsi

Employee

Geoff Thompson

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Catalyst Biosciences

DecImmune Therapeutics

GITR

Mosaic Biosciences

Pathogenetix

Promedior

Proteostasis Therapeutics

Radius Health

Senseonics

Theraclone Sciences

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.